.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Express Scripts
McKesson
Julphar
Colorcon
Baxter
Queensland Health
Fish and Richardson
Farmers Insurance
Covington

Generated: September 24, 2017

DrugPatentWatch Database Preview

OXYCODONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

What is the patent landscape for Oxycodone Hydrochloride, and when can generic versions of Oxycodone Hydrochloride launch?

Oxycodone Hydrochloride is a drug marketed by Novel Labs Inc, Mayne Pharma Inc, West-ward Pharms Int, Wes Pharma Inc, Vintage Pharms, Alvogen Malta, Hi-tech Pharmacal, Ascent Pharms Inc, Ken Lifescience, Pharm Assoc, Lannett Holdings Inc, Lehigh Valley, Actavis Elizabeth, Vistapharm, Amneal Pharms, Ani Pharms Inc, Wockhardt Bio Ag, Mallinckrodt Inc, Sun Pharm Inds Inc, Aurolife Pharma Llc, Epic Pharma Llc, Avanthi Inc, Nesher Pharms, Rhodes Pharms, Abhai Llc, Barr Labs Inc, and Watson Labs. and is included in forty-three NDAs.

The generic ingredient in OXYCODONE HYDROCHLORIDE is ibuprofen; oxycodone hydrochloride. There are sixty-four drug master file entries for this compound. Two suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the ibuprofen; oxycodone hydrochloride profile page.

Summary for Tradename: OXYCODONE HYDROCHLORIDE

Patents:0
Applicants:27
NDAs:43
Suppliers / Packagers: see list50
Bulk Api Vendors: see list24
Clinical Trials: see list2,554
Patent Applications: see list6,351
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:OXYCODONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: OXYCODONE HYDROCHLORIDE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nesher Pharms
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL077290-005Dec 8, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL203638-001Jun 3, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
CAPSULE;ORAL203823-001Aug 1, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Vistapharm
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
SOLUTION;ORAL201194-001Jan 12, 2012AARXYesYes► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL076758-003Mar 19, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Epic Pharma Llc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL202662-001Sep 22, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Amneal Pharms
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL203638-005Jun 3, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Mallinckrodt Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL076758-001Jun 30, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
OXYCODONE HYDROCHLORIDE
oxycodone hydrochloride
TABLET;ORAL090659-004Nov 6, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
OXYCODONE HYDROCHLORIDE AND IBUPROFEN
ibuprofen; oxycodone hydrochloride
TABLET;ORAL078394-001Nov 26, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Covington
Daiichi Sankyo
Colorcon
McKinsey
Mallinckrodt
Deloitte
Accenture
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot